Luoting Yu
Impact in
- Organic Chemistry top 2%
- Synthesis and biological activity
- Asymmetric Synthesis and Catalysis
- Synthesis and Characterization of Heterocyclic Compounds
- Toxicology top 2%
Papers in
-
- Epigenetics and DNA Methylation 20
- Cancer-related gene regulation 17
- Cancer therapeutics and mechanisms 14
- Protein Degradation and Inhibitors 13
- Ubiquitin and proteasome pathways 11
-
- Synthesis and biological activity 19
- Co-authors
- Tinghong Ye (42 shared papers)Ningyu Wang (55 shared papers)Yuquan Wei (26 shared papers)Yongxia Zhu (36 shared papers)Yong Xia (23 shared papers)Xuejiao Song (23 shared papers)Zhuo Tang (2 shared papers)Zhihao Liu (37 shared papers)
- Journals
- European Journal of Medicinal Chemistry (14 papers)Bioorganic & Medicinal Chemistry Letters (12 papers)RSC Advances (9 papers)Biomedicine & Pharmacotherapy (6 papers)Journal of Medicinal Chemistry (6 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Luoting Yu
135 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 100
- Organic Chemistry 1.1k
- Toxicology 95
- Molecular Biology 1.6k
- Oncology 476
- Cancer Research 201
Countries citing papers authored by Luoting Yu
This map shows the geographic impact of Luoting Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luoting Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luoting Yu more than expected).
Fields of papers citing papers by Luoting Yu
This network shows the impact of papers produced by Luoting Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luoting Yu. The network helps show where Luoting Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Luoting Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 390 | |
| 2 | 2014 | 112 | |
| 3 | 2021 | 95 | |
| 4 | 2017 | 76 | |
| 5 | 2018 | 68 | |
| 6 | 2016 | 64 | |
| 7 | 2020 | 61 | |
| 8 | 2010 | 60 | |
| 9 | 2011 | 58 | |
| 10 | 2013 | 56 | |
| 11 | 2014 | 56 | |
| 12 | 2012 | 56 | |
| 13 | 2016 | 51 | |
| 14 | 2016 | 50 | |
| 15 | 2018 | 48 | |
| 16 | 2014 | 45 | |
| 17 | 2008 | 43 | |
| 18 | 2011 | 42 | |
| 19 | 2015 | 41 | |
| 20 | Repositioning antipsychotic fluphenazine hydrochloride for treating triple negative breast cancer with brain metastases and lung metastases. | 2019 | 41 |
About Luoting Yu
Luoting Yu is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Infectious Diseases and Cancer Research, having authored 141 papers that have together received 2.9k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (20 papers), Synthesis and biological activity (19 papers), Cancer-related gene regulation (17 papers), Cancer therapeutics and mechanisms (14 papers), Protein Degradation and Inhibitors (13 papers), Cancer-related Molecular Pathways (11 papers), Ubiquitin and proteasome pathways (11 papers) and Microtubule and mitosis dynamics (10 papers). The work is most often cited by research in Organic Chemistry (1.1k citations), Toxicology (95 citations), Molecular Biology (1.6k citations), Oncology (476 citations) and Cancer Research (201 citations). Luoting Yu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Tinghong Ye, Ningyu Wang, Yuquan Wei, Yongxia Zhu, Yong Xia, Xuejiao Song, Zhuo Tang, Zhihao Liu, Qian Lei and Aiqiao Mi. Their work appears in journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, RSC Advances, Biomedicine & Pharmacotherapy and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.